Zepp Health Return on Investment 2017-2025 | ZEPP
Current and historical return on investment (ROI) values for Zepp Health (ZEPP) over the last 10 years.
| Zepp Health ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-09-30 | $-0.03B | $0.31B | -11.13% |
| 2025-06-30 | $-0.05B | $0.32B | -14.34% |
| 2025-03-31 | $-0.05B | $0.34B | -14.67% |
| 2024-12-31 | $-0.05B | $0.37B | -13.00% |
| 2024-09-30 | $-0.04B | $0.41B | -9.37% |
| 2024-06-30 | $-0.02B | $0.43B | -5.55% |
| 2024-03-31 | $-0.02B | $0.46B | -5.28% |
| 2023-12-31 | $-0.03B | $0.48B | -6.28% |
| 2023-09-30 | $-0.04B | $0.48B | -8.10% |
| 2023-06-30 | $-0.05B | $0.49B | -10.27% |
| 2023-03-31 | $-0.06B | $0.50B | -11.35% |
| 2022-12-31 | $-0.06B | $0.51B | -11.70% |
| 2022-09-30 | $-0.04B | $0.53B | -7.90% |
| 2022-06-30 | $-0.02B | $0.55B | -3.83% |
| 2022-03-31 | $-0.01B | $0.53B | -2.27% |
| 2021-09-30 | $0.02B | $0.50B | 4.82% |
| 2021-06-30 | $0.03B | $0.46B | 5.70% |
| 2021-03-31 | $0.02B | $0.32B | 5.03% |
| 2020-12-31 | $0.03B | $0.21B | 13.06% |
| 2020-09-30 | $0.05B | $0.10B | 47.12% |
| 2020-06-30 | $0.07B | 0 | 0.00% |
| 2020-03-31 | $0.08B | 0 | 0.00% |
| 2019-12-31 | $0.09B | 0 | 0.00% |
| 2019-09-30 | $0.07B | 0 | 0.00% |
| 2019-06-30 | $0.06B | 0 | 0.00% |
| 2019-03-31 | $0.06B | 0 | 0.00% |
| 2018-12-31 | $0.05B | 0 | 0.00% |
| 2018-09-30 | $0.15B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.189B | $0.259B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |